Application Information

This drug has been submitted to the FDA under the reference 202813/001.

Names and composition

"QNASL" is the commercial name of a drug composed of BECLOMETHASONE DIPROPIONATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
202813/001 QNASL BECLOMETHASONE DIPROPIONATE AEROSOL, METERED/NASAL 0.08MG per ACTUATION
202813/002 QNASL BECLOMETHASONE DIPROPIONATE AEROSOL, METERED/NASAL 0.04MG per ACTUATION

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
017573/001 VANCERIL BECLOMETHASONE DIPROPIONATE AEROSOL, METERED/INHALATION 0.042MG per INH
018153/001 BECLOVENT BECLOMETHASONE DIPROPIONATE AEROSOL, METERED/INHALATION 0.042MG per INH
018521/001 VANCENASE BECLOMETHASONE DIPROPIONATE AEROSOL, METERED/NASAL 0.042MG per INH
018584/001 BECONASE BECLOMETHASONE DIPROPIONATE AEROSOL, METERED/NASAL 0.042MG per INH
020486/001 VANCERIL DOUBLE STRENGTH BECLOMETHASONE DIPROPIONATE AEROSOL, METERED/INHALATION 0.084MG per INH
020911/001 QVAR 80 BECLOMETHASONE DIPROPIONATE AEROSOL, METERED/INHALATION 0.08MG per INH
020911/002 QVAR 40 BECLOMETHASONE DIPROPIONATE AEROSOL, METERED/INHALATION 0.04MG per INH
202813/001 QNASL BECLOMETHASONE DIPROPIONATE AEROSOL, METERED/NASAL 0.08MG per ACTUATION
202813/002 QNASL BECLOMETHASONE DIPROPIONATE AEROSOL, METERED/NASAL 0.04MG per ACTUATION

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved